CAS RN: 1417162-36-7
RI-2
Product Availability
Choose a grade to view its available package options.
6 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250711 |
2mg / 5mg |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250409 |
100mg |
Out of stock |
| | Inquiry |
| Batchno.20250410 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260315 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260414 |
50mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250721 |
5mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS1417162-36-7
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1417162-36-7 / 1-(3,4-dichlorophenyl)-3-(4-methoxyphenyl)-4-morpholin-4-ylpyrrole-2,5-dione
Standard CAS: 1417162-36-7
Multi CAS: No
Basic Information
CAS
1417162-36-7
Multi CAS
No
Molecular Formula
C21H18Cl2N2O4
Molecular Weight
433.300000
Exact Mass
432.064362
SMILES
COC1=CC=C(C=C1)C2=C(C(=O)N(C2=O)C3=CC(=C(C=C3)Cl)Cl)N4CCOCC4
InChI
InChI=1S/C21H18Cl2N2O4/c1-28-15-5-2-13(3-6-15)18-19(24-8-10-29-11-9-24)21(27)25(20(18)26)14-4-7-16(22)17(23)12-14/h2-7,12H,8-11H2,1H3
InChIKey
JMPJNNOSVCHYOU-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
29
Aromatic heavy atom count
12
Fraction Csp3
0.24
Rotatable bonds
4
H-bond acceptors
5
Molar refractivity
111.26
TPSA
59.08
LogP / Solubility
WLOGP
3.62
MLOGP
3.21
XLogP3
3.9
Consensus LogP
3.58
Log S (ESOL)
-4.85
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.73
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.96
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.79
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3